| Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213) |
|---|
| 09/07/2005 | CN1665401A Vitamin-containing system for stabilising the immune response of animals |
| 09/07/2005 | CN1217698C Activation and protection of T-cells (CD4+ and CD8+) using and H2 receptor agonist and other T-cell activating agents |
| 09/07/2005 | CN1217689C Houpo Huanglian Ye (magnolia coptis liguor) for treating piles |
| 09/07/2005 | CN1217683C Prescription of lotion for treating pile and fistula and its preparing process |
| 09/07/2005 | CN1217682C Medicine for treating epilepsis |
| 09/07/2005 | CN1217681C Externally applied paste for treating fracture and injured tendons and its preparing method |
| 09/07/2005 | CN1217679C Traditional Chinese medicinal powder pasted on shenchueh acupoint for treating astriction |
| 09/07/2005 | CN1217673C Chinese medicine for fuming and washing piles and its preparation process |
| 09/07/2005 | CN1217670C Lubricating fluid for sexual intercourse |
| 09/06/2005 | US6939860 Composition and method for treatment of neoplastic diseases associated with elevated matrix metalloproteinase activities using catechin compounds |
| 09/06/2005 | US6939715 Method for producing purified hematinic iron-saccharidic complex and product produced |
| 09/06/2005 | US6939568 Hydrated dressing containing metal microbiocide |
| 09/06/2005 | US6939567 Pharmaceutical ayurvedic preparation |
| 09/06/2005 | US6939561 Methods and compositions for polyene antibiotics with reduced toxicity |
| 09/06/2005 | CA2119516C Ointment for wound treatment |
| 09/01/2005 | WO2005079857A1 Galactomannans and/or glucomannans for increasing the bioavailability of active substances |
| 09/01/2005 | WO2005079818A1 Glycerol solution containing dissolved ozone, solidified glycerol containing dissolved ozone, mixed solution containing dissolved ozone, process for producing glycerol solution containing dissolved ozone, process for producing mixed solution containing dissolved ozone, and method of storing glycerol solution containing diss |
| 09/01/2005 | WO2005079781A1 Therapeutic and/or prophylactic method |
| 09/01/2005 | WO2005079738A1 Antimicrobial formulations and methods of using the same |
| 09/01/2005 | WO2005079736A1 Composition for treating a dermatological inflammatory response and method of preparation thereof |
| 09/01/2005 | WO2005079514A2 Preservation of blood vessels for grafting using inhibitors of tnf-alpha |
| 09/01/2005 | US20050192235 Compositions and methods for treating or preventing diseases of body passageways |
| 09/01/2005 | US20050191395 Hangover remedy and alcohol abatement composition |
| 09/01/2005 | US20050191394 combining sulfuric acid of approximately 94% purity to approximately 99.9% purity in a 1 to 2 volume ratio with distilled water and ammonium sulfate; adding a compound containing metallic ions to mixture |
| 09/01/2005 | US20050191372 Device and method for treatment of wounds with nitric oxide |
| 09/01/2005 | US20050191371 Medical composition |
| 09/01/2005 | US20050191370 Combination elicites an antioxidant effect, increase the mean diameter of the strands of hair, decrease the heterogeneity of the diameters of the hairs and increase hair density, thus reflecting regrowth |
| 09/01/2005 | US20050191369 Compositions comprising vitamin E and saw palmetto |
| 09/01/2005 | US20050191368 for administration to male for treating or preventing prostate disease and/or vascular disease, the active components including saw palmetto, vitamin E, selenium, lycopene, zinc, vitamin B12, vitamin B6 and folic acid |
| 09/01/2005 | US20050191367 Administering a therapeutically effective amount of arsenic compounds, optionally along with other non-arsenic therapeutic agents, to a mammal for treating solid tumors |
| 09/01/2005 | US20050191365 Uniform suspension of sulfuric acid, ammonium sulfate andmetallic ions; salmonella, stahphylococcus, listeria, E-coli |
| 09/01/2005 | US20050191364 Use of enhanced water to improve blood sugar management |
| 09/01/2005 | US20050191349 Sustained release; fast dissolving; for treatment of Alzheimer's disease |
| 09/01/2005 | US20050191345 Temperature-sensitive liposomal formulation |
| 09/01/2005 | US20050191314 vaccine comprosing a mixture of A beta oligomers capable of generating an immune response; prophylaxis and treatment of Alzheimer's disease |
| 09/01/2005 | US20050191292 of reversing cognitive decline by administering a humanized antibody that binds to A beta; particularly useful for prophylactic and therapeutic treatment of Alzheimer's disease or Down's syndrome. |
| 09/01/2005 | US20050191267 Mulberry extract; whitening effects for darkened skin through antityrosinase activity, antioxidant and anti-inflammatory properties |
| 09/01/2005 | US20050191251 Anhydrous bleaching paste comprising at least one ceramide-type compound and method using it |
| 09/01/2005 | US20050191248 such as silk or bleomycin; treatment for a dental condition such as periodontal disease |
| 09/01/2005 | DE102004005788A1 Zubereitungen enthaltend Echinacea-Auszüge und Thiocyanat Preparations containing Echinacea extracts and thiocyanate |
| 09/01/2005 | CA2558475A1 Antimicrobial formulations and methods of using the same |
| 09/01/2005 | CA2553367A1 Composition for treating a dermatological inflammatory response and method of preparation thereof |
| 08/31/2005 | EP1567451A2 Rare earth compositions and structures for removing phosphates from water |
| 08/31/2005 | EP1567198A2 Materials and methods for treating ocular-related disorders |
| 08/31/2005 | EP1567193A1 Colon cleansing compositions |
| 08/31/2005 | EP1567174A2 Compositions for diabetes treatment and prophylaxis |
| 08/31/2005 | EP1567144A2 Method of making, and the use of cytotoxic agents containing elemental selenium |
| 08/31/2005 | EP1567121A2 Nanoparticulate redispersible zinc-oxide powder |
| 08/31/2005 | EP1567101A2 Prophylactic treatment methods |
| 08/31/2005 | EP1492548B1 Composition for the topical treatment of vulvovaginitis and mycoses |
| 08/31/2005 | EP1448246B1 Homogeneously coated device having osteoinductive and osteoconductive properties |
| 08/31/2005 | EP1401407B1 Porous sponge-like cellulosic material for treatment of injuries |
| 08/31/2005 | EP1224192B1 Half-sandwich ruthenium (ii) compounds comprising nitrogen containing ligands for treatment of cancer |
| 08/31/2005 | EP1185242B1 An anti-microbial body care product |
| 08/31/2005 | CN1662501A Cyanoguanidine prodrugs |
| 08/31/2005 | CN1662229A Use of taurine for the treatment of alopecia |
| 08/31/2005 | CN1660132A Combination for local use for preventing anti treating ocular disease |
| 08/31/2005 | CN1216644C Tin-117m-containing radio therapeutic agents |
| 08/31/2005 | CN1216635C Composition and method for curing diabetes |
| 08/31/2005 | CN1216631C Blood quickening statis transforming plaster |
| 08/31/2005 | CN1216626C Shenhong capsule with actions of removing blood stasis and obstruction |
| 08/31/2005 | CN1216620C Composite medicine for treating leukemia |
| 08/31/2005 | CN1216615C Plaster for treating rheumatic diseases and psoatic strain and its prepn process |
| 08/30/2005 | US6936634 Ruthenium (II) compounds for use in the therapy of cancer |
| 08/30/2005 | US6936452 Inhibitors of the inositol polyphosphate 5-phosphate SHIP2 molecule |
| 08/30/2005 | US6936286 Combination of specific vitamins, minerals, herbs and nutrients. These essential components in the amounts provided uniquely contribute to improved blood sugar levels and insulin delivery to the cells. The formulation contains essential |
| 08/30/2005 | US6936280 Method for preparing a composition by extraction of mother-of-pearl, composition obtained by said method and use thereof in cosmetics and dermatology |
| 08/30/2005 | US6936267 Anti-acne compositions and methods of use |
| 08/30/2005 | US6935334 Enhancing therapeutic effectiveness of nitric oxide inhalation |
| 08/30/2005 | US6935271 Method for producing a bovine teat dip |
| 08/30/2005 | CA2359559C Microdermabrasion device |
| 08/25/2005 | WO2005077405A1 Compositions and methods for the treatment of cancer by systemic elevation of lactate and consequent depletion of arginine |
| 08/25/2005 | WO2005077387A1 Spermicidal preparations and uses thereof |
| 08/25/2005 | WO2005077386A1 Composition and method for use in cartilage affecting conditions |
| 08/25/2005 | WO2005077385A2 Methods for treating resistant or refractory tumors |
| 08/25/2005 | WO2005077189A1 Method of treatment |
| 08/25/2005 | WO2005077005A2 Enhancing the effectiveness of an inhaled therapeutic gas |
| 08/25/2005 | WO2005076819A2 Chlorite in the treatment of neurodegenerative disease |
| 08/25/2005 | WO2005041656A3 Methods, compositions and devices for inducing stasis in tissues and organs |
| 08/25/2005 | WO2005039291A3 Methods, compositions and devices for inducing stasis in cells |
| 08/25/2005 | US20050187144 Combinations of chromium or vanadium with antidiabetics for glucose metabolism disorders |
| 08/25/2005 | US20050186289 Regulation of T cell-mediated immunity by D isomers of inhibitors of indoleamine-2,3-dioxygenase |
| 08/25/2005 | US20050186288 Compositions and methods for the prophylaxis and treatment of aphthous ulcers and herpes simplex lesions |
| 08/25/2005 | US20050186287 Use of copper agonists such as divalent metal ions, oligopeptides, oligonucleotides, oligosaccharides, nucleotide analogs that bind to copper binding site of amyloid precursor protein and reduce or prevent release of amyloid A beta peptide; prevention or treatment of Alzheimer's disease |
| 08/25/2005 | US20050186269 Stabilized feverfew formulations |
| 08/25/2005 | US20050186247 Such as silk, which induce a fibrotic response in the surrounding tissue such that the device is anchored in situ and its performance is enhanced; prosthetic joint for example |
| 08/25/2005 | US20050186135 therapy for tumors, lesions, cancer by in situ supplying peroxide and hypochlorite; drug delivery |
| 08/25/2005 | US20050185069 Still camera with audio decoding and coding, a printable audio format, and method |
| 08/25/2005 | DE102004006829A1 Cosmetic composition for e.g. preventing or treating acne or sebum production contains actives combination of isoflavones and antiperspirants |
| 08/25/2005 | CA2838392A1 Chlorite in the treatment of neurodegenerative disease |
| 08/25/2005 | CA2555811A1 Methods for treating resistant or refractory tumors |
| 08/25/2005 | CA2554511A1 Chlorite in the treatment of neurodegenerative disease |
| 08/25/2005 | CA2553748A1 Composition and method for use in cartilage affecting conditions |
| 08/24/2005 | EP1565195A1 Anticancer or antiviral composition |
| 08/24/2005 | EP1032406B1 Reducing blood cholesterol by in vivo precipitation of bile constituents with group ii or -iii metal substances |
| 08/24/2005 | EP0914102B1 Compositions and methods for treating or preventing diseases of body passageways |
| 08/24/2005 | CN1658913A Strontium-apatite-cement-preparations, cements formed therefrom, and uses thereof |
| 08/24/2005 | CN1658889A Methods of treating ileus |
| 08/24/2005 | CN1657057A Pure natural cheap weight-reducing agent-bittern |
| 08/24/2005 | CN1657056A Preparation and use of vasodilation liquid |